These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
66 related articles for article (PubMed ID: 1888156)
1. Intravesical Bacillus Calmette-Guérin treatment for superficial bladder cancer: results after 15 years of experience. van der Meijden AP; Steerenberg PA; de Jong WH; Debruyne FM Anticancer Res; 1991; 11(3):1253-8. PubMed ID: 1888156 [TBL] [Abstract][Full Text] [Related]
2. High grade superficial (G3t1) transitional cell carcinoma of the bladder treated with intravesical Bacillus Calmette-Guerin (BCG). Pansadoro V; Emiliozzi P; depaula F; Scarpone P; Pizzo M; Federico G; Martini M; Pansadoro A; Sternberg CN J Exp Clin Cancer Res; 2003 Dec; 22(4 Suppl):223-7. PubMed ID: 16767936 [TBL] [Abstract][Full Text] [Related]
3. Intravesical Bacillus Calmette-Guérin therapy for murine bladder tumors: initiation of the response by fibronectin-mediated attachment of Bacillus Calmette-Guérin. Ratliff TL; Palmer JO; McGarr JA; Brown EJ Cancer Res; 1987 Apr; 47(7):1762-6. PubMed ID: 3545453 [TBL] [Abstract][Full Text] [Related]
4. Non specific immunotherapy with B.C.G. in superficial bladder cancer: an overview. Van der Meijden AP In Vivo; 1991; 5(6):599-604. PubMed ID: 1810445 [TBL] [Abstract][Full Text] [Related]
5. Immunoprophylactic intravesical application of bacillus Calmette-Guerin after transurethral resection of superficial bladder cancer. Librenjak D; Situm M; Eterovic D; Dogas Z; Gotovac J Croat Med J; 2003 Apr; 44(2):187-92. PubMed ID: 12698510 [TBL] [Abstract][Full Text] [Related]
7. The effect of intravesical instillation of antifibrinolytic agents on bacillus Calmette-Guerin treatment of superficial bladder cancer: a pilot study. Pan CW; Shen ZJ; Ding GQ J Urol; 2008 Apr; 179(4):1307-11; discussion 1311-2. PubMed ID: 18289576 [TBL] [Abstract][Full Text] [Related]
8. Mathematical model of pulsed immunotherapy for superficial bladder cancer. Bunimovich-Mendrazitsky S; Byrne H; Stone L Bull Math Biol; 2008 Oct; 70(7):2055-76. PubMed ID: 18716846 [TBL] [Abstract][Full Text] [Related]
9. [Bacillus Calmette Guerin as adjuvant treatment for superficial bladder tumors using two different therapeutic schemes]. Iturralde Codina A; Beyríe Tamayo W; Gozá León F; Muñoz YI Arch Esp Urol; 2004; 57(6):606-18. PubMed ID: 15382436 [TBL] [Abstract][Full Text] [Related]
10. [Intravesical adjuvant chemotherapy for superficial bladder cancer -- results of a survey in Saxony]. Steinbach F; Schuster F Aktuelle Urol; 2005 Aug; 36(4):337-41. PubMed ID: 16110407 [TBL] [Abstract][Full Text] [Related]
12. The expression level of ligands for natural killer cell receptors predicts response to bacillus Calmette-Guerin therapy: a pilot study. Yutkin V; Pode D; Pikarsky E; Mandelboim O J Urol; 2007 Dec; 178(6):2660-4. PubMed ID: 17945285 [TBL] [Abstract][Full Text] [Related]
13. Editor's choice: Implications of isoniazid resistance in Mycobacterium bovis Bacillus Calmette-Guérin used for immunotherapy in bladder cancer. Watts MR; Taylor PC; Sintchenko V; Whelan CM; Farnsworth RH; Jones P; Jelfs P; Carr D; Goldberg H Clin Infect Dis; 2011 Jan; 52(1):86-8. PubMed ID: 21148524 [TBL] [Abstract][Full Text] [Related]
14. Bladder contracture: review for intravesical bacillus Calmette-Guerin complication. Hameed A; Sezian N; Thwaini A Can J Urol; 2007 Dec; 14(6):3745-9. PubMed ID: 18163926 [TBL] [Abstract][Full Text] [Related]
15. Combined thermo-chemotherapy for recurrent bladder cancer after bacillus Calmette-Guerin. Nativ O; Witjes JA; Hendricksen K; Cohen M; Kedar D; Sidi A; Colombo R; Leibovitch I J Urol; 2009 Oct; 182(4):1313-7. PubMed ID: 19683278 [TBL] [Abstract][Full Text] [Related]
16. Intravesical bacillus Calmette-Guérin therapy for T1 superficial bladder cancer. Demkow T; Alter A; Wiechno P Urol Int; 2008; 80(1):74-9. PubMed ID: 18204238 [TBL] [Abstract][Full Text] [Related]
17. Intravesical instillation therapy with bacillus Calmette-Guérin for superficial bladder cancer: study of the mechanism of bacillus Calmette-Guérin immunotherapy. Shintani Y; Sawada Y; Inagaki T; Kohjimoto Y; Uekado Y; Shinka T Int J Urol; 2007 Feb; 14(2):140-6. PubMed ID: 17302571 [TBL] [Abstract][Full Text] [Related]
18. Urinary Interleukin-8 and 18 predict the response of superficial bladder cancer to intravesical therapy with bacillus Calmette-Guerin. Thalmann GN; Sermier A; Rentsch C; Möhrle K; Cecchini MG; Studer UE J Urol; 2000 Dec; 164(6):2129-33. PubMed ID: 11061941 [TBL] [Abstract][Full Text] [Related]
19. Reduction of bladder tumor growth in mice treated with intravesical Bacillus Calmette-Guérin and its correlation with Bacillus Calmette-Guérin viability and natural killer cell activity. Shapiro A; Ratliff TL; Oakley DM; Catalona WJ Cancer Res; 1983 Apr; 43(4):1611-5. PubMed ID: 6339040 [TBL] [Abstract][Full Text] [Related]